The DNA methylation at the FMR1 locus was more variable in the FXS ESCs compared to the DNA methylation at the FXN locus in FRDA iPSCs at all time points in both cells expressing MSH2 and those that did not. The gene discussed is FXN; the disease is fragile X syndrome.